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Most neuropsychiatric diseases have a sex bias in their presentation, age of onset, or treatment response.
Yet surprisingly, we have considered very little the contribution of the sexually dimorphic brain when thinking
about disease etiology and the important influences of the neuroendocrine and immune systems in program-
ming the CNS.‘‘It’s not stress that kills us, it is our
reaction to it’’
—Hans Selye
But are those reactions dependent on our
sex?
The Enigmatic Sexually Dimorphic
Brain
The complex sexually dimorphic brain is an
intricate puzzle from which we are piecing
together similarities and differences
between the sexes for disease onset,
development, and progression. As many
neuropsychiatric disorders have a sex
bias, elucidation of what makes the male
brain different from the female brain and
when in development and maturation
such sex differences are important may
prove enlightening if we want to identify
novel therapeutic targets and treatments.
Sex differences are important to consider
for both how the organism responds or
copes with neuroendocrine or immune
challenges to homeostasis, such as stress
or infection, as well as for how such pertur-
bations may then feed back to program
long-term changes in future responses.
This idea of a G3E3D (or how our Genes
are affected by the Environment during
Developmental periods) interaction has
been a recent focal point of the National
Institute for Mental Health and its Director,
Thomas Insel. The identification of envi-
ronmental programming effects on novel
genes during sensitive and dynamic
periods of brain development and matura-
tion has greatly pushed forward our under-
standing of disease susceptibility. There is
no doubt that sex factors into this equa-
tion, but its contribution at a mechanistic
level has been greatly ignored. How canthis be? With women presenting with
affective disorders at two to three times
the rate of men, with autism affecting four
times as many boys as girls, and with
schizophrenia and depression onset
dramatically rising during the adolescent
years when major sex differences in brain
maturation occur, taking a closer look at
why sex matters seems a question of
fundamental importance.
In the absence of gonadal hormones
during the sensitive period, the default
brain is female.well, almost. The effect
of the perinatal testosterone surge is to
masculinize the male brain. In the
absence of this hormonal trigger, typical
differences between sexually dimorphic
nuclei will likely never develop. However,
application of testosterone to a female
during this organizational period or to a
male outside this period produces a brain
that is neither fully male nor female. Not
surprisingly, our chromosomal sex can
also contribute to brain development in a
hormone-independent manner. Evidence
supporting this idea has come from
many studies, including Art Arnold’s
development of the four core genotype
mice where the testis-determining SRY
gene is autosomal, providing a novel
tool with which the contribution of sex
chromosome complement can be disso-
ciated from gonadal sex to address
important questions regarding sex differ-
ences (Arnold and Chen, 2009).
The timing or ‘‘critical periods’’ of brain
development demarcate points where
the plastic brain undergoes dramatic
changes that are distinctly feminine or
masculine, with sexually dimorphic nuclei
increasing or decreasing in size, synapse
and glia numbers changing, and dendriticNeuronspines sprouting at a rapid rate. However,
an aspect of disease mechanism that has
been greatly overlooked is the examina-
tion of how these sex-specific states
may present as a window of vulnerability,
where the normal developmental trajec-
tory becomes most susceptible to reprog-
ramming. For instance, in both humans
and rodents, portions of the limbic sys-
tem that are involved in stress regulation
and emotional affect undergo significant
maturation during adolescence, where
amygdala volume increases significantly
more in boys, while hippocampal volume
increases faster in girls. Interestingly,
these same limbic and forebrain regions
are extremely sensitive to stress (McE-
wen, 2005). Logic would follow that as
glucocorticoids are potent modulators of
synaptic function and plasticity, exposure
to stressors during adolescence could
shape these areas critical to emotionality
in a sex-dependent manner (Goel and
Bale, 2009). Unfortunately, while studies
have begun to focus on the long-term
consequences of stress during adoles-
cence as a predetermining factor in
disease, sex-specificity for outcomes has
not been included as a possible factor. As
adolescence is a period of increased
presentation of mental health disorders,
it will be imperative to better identify
and delineate these interactions between
adolescent brain maturation, environ-
mental influences, and sex.
Sex, Stress, and Affective Disorders
One example where these factors may
come together to mediate brain dysfunc-
tion is the case of affective disorders.
We have become increasingly aware
that females are diagnosed with affective64, October 15, 2009 ª2009 Elsevier Inc. 13
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males, while we still know astonishingly
little regarding potential mechanisms
underlying such sex differences. Clinical
studies have pinpointed stress sensitivity
or stress pathway dysregulation as a
strong risk factor in affective disorder
onset and susceptibility. Notably, in both
humans and rodents, females show a
postpubertal increase in stress response
magnitude and a more prolonged stress
recovery time compared to males.
Orchestration of the stress response
and recovery can be influenced by a host
of neuroendocrine and immune factors
and may have long-term consequences
related to the future sensitivity and
susceptibility of the organism. Therefore,
the continued ability throughout life to
appropriately respond tostress is a neces-
sary aspect in homeostatic maintenance
and disease prevention. Interestingly,
dysregulation of the hypothalamic-pitui-
tary-adrenal (HPA) stress axis, defined as
inappropriate stress responsivity, be it
too high or too low, is the most common
and predictive physiological symptom in
neuorpsychiatric disease. However, it is
not yet clear whether changes in HPA
axis hormones are a primary contributor
or a secondary response to an as yet
undetermined cause.
The Immunological Intersection
Interestingly, there is a recent apprecia-
tion for the direct impact of the immune
system on the stress axis and its potential
involvement in stress-induced affective
disorder onset and progression. Why is
this important now? From early work by
the famed endocrinologist Hans Selye,
we have long understood the role that
stress axis glucocorticoids play in damp-
ening the immune system, and in more
recent studies that within the brain these
same steroid hormones can enhance
immune function via direct actions on
microglia (Sorrells et al., 2009 [this issue
of Neuron]). However, as is often the
case in organismal maintenance where
endocrine system feedback works to
promote homeostasis, the converse also
rings true—proinflammatory cytokines
and immune activation are potent stimula-
tors of the HPA stress axis and are thought
to function during chronic inflammation to
promote cytokine-dependent glucocorti-
coid receptor resistance. More directly,14 Neuron 64, October 15, 2009 ª2009 Elsecytokines also have an effect on pro-
moting release of CRF, a likely candidate
for many of the symptoms presented in
affective disorders (Irwin and Miller, 2007).
Could there be sex differences in how
the immune system interacts with these
outcomes or in the link between inflam-
mation and affective disorders? Certainly,
there are well-examined immunosuppres-
sive effects of the gonadal hormone rise
during pregnancy, promoting a vulnera-
bility of the pregnant host to infection
(Butts and Sternberg, 2008). However,
less is understood at the cellular level as
to specific innate sex differences in the
ability of immune molecules to alter stress
responsivity or influence affect. Interest-
ingly, in a preponderance of human auto-
immune diseases including multiple scle-
rosis and lupus erythematosus, there is
also a sex difference with greater preva-
lence in women. Here too, the neuroendo-
crine stress axis intersects with immune
function, greatly exacerbating disease
symptoms.
Where do we begin for understanding
the influence of neuroendocrine and
immune systems on sex differences? If
we first back up and examine how the
sexually dimorphic brain develops, we
find intriguing evidence in support of the
immune system’s influence on important
sex differences even at the cellular level
beginning very early in CNS development.
Margaret McCarthy’s laboratory has
elegantly demonstrated in rats that brain
masculinization by estrogen during the
perinatal sensitive period occurs through
prostaglandin-dependent mechanisms
and can be blocked by a COX-2 inhibitor,
supporting a critical role for neuroimmune
signals in programming of the sexually
dimorphic brain (Amateau and McCarthy,
2004). So, at a very early point in develop-
ment we find evidence for a critical inter-
action between neuroendocrine-neuroim-
mune pathways that is involved in
establishing sex differences.
In addition to helping program the sexu-
ally dimorphic brain, the neuroimmune
system also plays an important role in
regulation of various neurotransmitters
important in stress response throughout
life. One example involves the kynurenine
pathway and its potent stimulation by
proinflammatory cytokines. In the brain,
tryptophan is degraded by the cytokine-
inducible enzyme indoleamine 2,3 dioxy-vier Inc.genase (IDO). Fluctuations of IDO activity
following inflammation can have a direct
effect on tryptophan availability and
hence the amount of serotonin synthe-
sized, which is clearly critical in mainte-
nance of mental health and has been
associated with the development of major
depression and schizophrenia (Dantzer
et al., 2008). Since stress hormones also
have direct actions on cytokine produc-
tion via the glucocorticoid-induced TNF
receptor to induce IDO activity, the
increased stress response and reduced
recovery in females could further alter
tryptophan metabolism and 5-HT avail-
ability. During stress experience, reduced
5-HT production is prohibitive to adaptive
coping abilities and can greatly contribute
to learned helplessness, where in humans
such passive responses to stress are
highly associated with the occurrence of
depressive symptoms. Overall, there
appear to be multitudes of paths in which
fundamental sex differences beginning
early in brain development, through
dynamic periods of maturation and
throughout life, can collide to push an
organism into disease susceptibility.
Clinically, understanding such sex-
dependent mechanisms becomes impor-
tant in diagnosis as well as in designing
treatments with greater efficacy. As men
and women are viewed as having a
distinctly different brain development and
maturation, then it would follow that one
drug ‘‘size’’ would not fit all. For instance,
we know that in women the acute phase
of antidepressant therapy frequently
increases anxiety rather than decreasing
it. Further, if we factor in developmental
timing, where adolescence is distinct
from adulthood, SSRI treatments have
been associated with an increased risk
for suicidal thoughts and behavior. While
little has been examined as to potential
sex differences in these measures, based
on the dynamic state of the adolescent
brain it seems a necessary question to be
addressed. Here again, we turn our atten-
tion to the importance of sex differences
intersecting with developmental stages
when determining disease outcome.
Points of Vulnerability: The Road
Less Taken
While we now understand more about
the importance of gonadal hormones,
chromosomal sex, and the neuroimmune
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the sexually dimorphic brain, the potential
for early life insults to alter this trajectory
and its relevance to disease are less
clear. Fetal antecedents, postnatal dis-
turbances, or childhood trauma have
increasingly been associated with long-
term disease risk in depression, anxiety,
schizophrenia, and autism (Gardener
et al., 2009; Goel and Bale, 2009; Heim
et al., 2008). However, despite an obvious
sex bias in these diseases, surprisingly
little has been examined as to how such
early life experiences may alter perinatal
or adolescent sexually dimorphic brain
development and plasticity. Imaging
studies in clinical evaluation of sex differ-
ences in affective disorders and schizo-
phrenic patients have revealed dysregula-
tion of the human neuroendocrine system
with fetal antecedents coinciding with
brain sexual differentiation (Goldstein,
2006) and a disruption of the normal sexu-
ally dimorphic ratio of orbitofrontal cortex
to amygdala in male schizophrenia
patients (Gur et al., 2004). Such clinical
findings support the need to identify
contributing factors in the disruption of
‘‘normal’’ sex differences related to neu-
rodevelopmental disease susceptibility,
be they insightful markers pointing to the
timing of an insult or as an underlying
mechanism of disease etiology.
Insults that specifically occur during
gestation have been highly associated
with the development of schizophrenia
and autism, where maternal stress or
infection by way of increasing the proin-
flammatory response is thought to
increase risk. Interestingly, playing right
into the hypothesis that development of
the sexually dimorphic brain may be
involved, these diseases have been
recently proposed as the hypo- or hyper-
masculinized brain in male patients,
respectively. Studies in rodent models
have examined the influence of prenatal
stress on a range of sex-dependent out-
comes, including hippocampal-depen-
dent learning and memory and adult
stress responsivity, illustrating the speci-
ficity of these outcomes to the timing of
stress exposure across pregnancy (Muel-
ler and Bale, 2008). Not surprisingly, these
studies support a likely feminization of
males exposed to stress during early
development, where spatial learning and
memory, stress hormone responses, andphysiological characteristics of stressed
males show a pattern more similar to
females. These studies suggest a possible
disruption in the process of normal
masculinization of the sexually dimorphic
brain by maternal experience. Recent
epidemiological studies found a similar
association between maternal stress
experience during the first trimester with
an increased risk of schizophrenia in
males (Khashan et al., 2008). As the brain
is less likely to be the direct target
during this time, a candidate target
tissue for mechanistic examination is the
placenta, where influences of early gesta-
tional perturbations affecting develop-
mental programming in humans and
rodents may contribute to changes in
maternal hormones or placental gene
expression patterns impacting the devel-
oping embryo throughout gestation. It
turns out that the placenta is actually sex
specific, developing predominantly out of
the embryo with less contribution from
the mother. These data point to an exciting
and novel involvement of chromosomal
sex and a sex-specific interaction with
the maternal hormonal milieu, inflamma-
tory responses, and nutrient transport
and growth support of the developing
fetus.
Focusing on early programming events
in disease susceptibility leads us to an
important mode of regulation that has
yet to be tapped for sex differences—
epigenetics. The recent surge of neuro-
scientists incorporating epigenetics into
their research demonstrates a rethinking
of disease etiology. Where our tunnel
vision around genetic inheritance had
been limited to DNA sequence and single-
nucleotide polymorphisms, an apprecia-
tion has surfaced for the contribution
made by the environment and experience
as also heritable through DNA methyla-
tion, histone acetylation, and microRNAs.
In animal models, epigenetic analyses
have been applied to the examination of
long-term outcomes and transgenera-
tional effects of maternal care, diet,
stress, or infection to identify specific
genes associated with disease endophe-
notypes (Fagiolini et al., 2009). While
a great body of work has examined the
critical role for DNA methylation in the
imprinting essential for normal mamma-
lian development, we know much less
about how this machinery itself is regu-Neuronlated and what contribution to sex-depen-
dent outcomes it might play. Intriguing
sex differences exist in the expression
patterns for the epigenetic machinery
tied to regulating methylation and acetyla-
tion patterns. For instance, females typi-
cally have much greater levels of DNA
methyl transferase enzymes and methyl-
binding proteins in many tissues including
the brain and placenta. Further, there are
sex-chromosome-specific histone deme-
thylases, Utx and Uty. How sex specificity
in epigenetic machinery may relate to
programming of the sexually dimorphic
brain or potential differences in sex-
biased disease is not clear but is likely
again to point to developmental windows
of vulnerability where gene targets could
be identified.
Conclusions
At the crossroads of the developing and
maturing sexually dimorphic brain and
the challenges that pose a potential devi-
ation from this norm may lie the sex-
specific programming events contributing
toward disease susceptibility. Studies
herein afford us a great opportunity to
define disease mechanisms and novel
therapeutic targets and prevention. The
interaction of the neuroendocrine and
immune systems with brain sex is an
essential component of how the organism
copes and maintains homeostasis where
appropriate responses are necessary in
short- and long-term disease prevention.
These strategies are likely to be highly
individual and dependent on a host of
factors, with sex being a key contributor.
We have many miles to go to fully dissect
this enigmatic sexually dimorphic brain
and the diverse points along its route of
development and maturation where
detours are likely to reprogram the final
destination. Of clear importance in our
continuing studies is the appropriate
inclusion and evaluation of sex compari-
sons. Perhaps in solving this puzzle a
critical additional piece to the timing and
environmental equation needs to be G 3
E 3 D 3 S.
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